DUORESP

This brand name is authorized in Australia, Austria, Croatia, Estonia, France, Germany, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug DUORESP contains a combination of these active pharmaceutical ingredients (APIs):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide
2	Formoterol fumarate dihydrate UNII W34SHF8J2K - FORMOTEROL FUMARATE
	Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.
	Read more about Eformoterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AK07	Formoterol and budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11273H, 11301T, 12029D, 12093L
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07767644, 10192897, 10311037, 10311043, 10311072, 10311089, 10813187, 10813193, 10813224, 10813230, 11031736, 11031771, 11054476, 11054482, 11054507, 11054513, 11112452, 11112469, 11135022, 11135045, 11135051, 11174654, 11174683, 11174708, 11174720, 11183848, 11183854, 11183883, 11183908, 11251691, 11251716, 11296245, 11296274, 11339776, 11339782, 11339799, 11339807, 11551565, 11732597, 12308950, 12308967, 12387211, 12387228, 12387234, 12387240, 12450702, 12607859, 12607865, 12740067, 13839684, 14178486, 14178492, 15561543, 15561566, 15561595, 15561603, 16003495, 16033361, 16033378, 16742637
EE	Ravimiamet	1647086, 1647097, 1647109, 1647110, 1647121, 1647132
ES	Centro de información online de medicamentos de la AEMPS	114920001, 114920004
FR	Base de données publique des médicaments	61331495, 67827270
GB	Medicines & Healthcare Products Regulatory Agency	252542, 252549, 368894, 368896, 374345, 374347, 376316, 376318, 381301, 381303
IE	Health Products Regulatory Authority	53408, 53409, 53490, 53491
IL	מִשְׂרַד הַבְּרִיאוּת	7779, 7780
LT	Valstybinė vaistų kontrolės tarnyba	1073288, 1073289, 1073290, 1073291, 1073292, 1073293
NL	Z-Index G-Standaard, PRK	124176, 124184
NZ	Medicines and Medical Devices Safety Authority	19952, 19966
PL	Rejestru Produktów Leczniczych	100315522, 100315539
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63867001, W63868001